Neutrophil gelatinase-associated lipocalin in prediction of mortality in patients with hepatorenal syndrome: A prospective observational study

Liver International

Volumn 34, Issue 1, 2014, Pages 49-57

  Gungor, Gokhan ^a   Ataseven, Huseyin ^a   Demir, Ali ^a   Solak, Yalcin ^a   Gaipov, Abduzhappar ^a   Biyik, Murat ^a   Ozturk, Bahadir ^b   Polat, Ilker ^a   Kiyici, Aysel ^b   Cakir, Ozlem O ^a   Polat, Hakki ^a  

^a NECMETTIN ERBAKAN UNIVERSITY   (Turkey)

^b SELCUK UNIVERSITY   (Turkey)

Author keywords

Acute kidney injury; Cirrhosis; Hepatorenal syndrome; Mortality; Neutrophil gelatinase associated lipocalin

Indexed keywords

ALDOSTERONE; CREATININE; NEUTROPHIL GELATINASE ASSOCIATED LIPOCALIN; RENIN;

ACUTE KIDNEY FAILURE; ADULT; ALDOSTERONE BLOOD LEVEL; ARTICLE; ASCITES; COHORT ANALYSIS; CREATININE BLOOD LEVEL; DISEASE MARKER; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FOLLOW UP; HEPATORENAL SYNDROME; HUMAN; LIVER CIRRHOSIS; MAJOR CLINICAL STUDY; MALE; MORTALITY; OBSERVATIONAL STUDY; PLASMA RENIN ACTIVITY; PREDICTION; PROSPECTIVE STUDY; PROTEIN ANALYSIS; URINALYSIS;

ACUTE KIDNEY INJURY; CIRRHOSIS; HEPATORENAL SYNDROME; MORTALITY; NEUTROPHIL GELATINASE-ASSOCIATED LIPOCALIN;

ACUTE-PHASE PROTEINS; AGED; AREA UNDER CURVE; BIOLOGICAL MARKERS; CASE-CONTROL STUDIES; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HEPATORENAL SYNDROME; HOSPITAL MORTALITY; HUMANS; KAPLAN-MEIER ESTIMATE; LIPOCALINS; MALE; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; PROSPECTIVE STUDIES; PROTO-ONCOGENE PROTEINS; RISK FACTORS; ROC CURVE; TIME FACTORS;

EID: 84890125016     PISSN: 14783223     EISSN: 14783231     Source Type: Journal    
DOI: 10.1111/liv.12232     Document Type: Article

References (27)

1. Wong F. Recent advances in our understanding of hepatorenal syndrome. Nat Rev Gastroenterol Hepatol 2012a; 9: 382-91.
2. Angeli P, Morando F, Cavallin M, Piano S. Hepatorenal syndrome. Contrib Nephrol 2011; 174: 46-55.
3. Schrier RW, Shchekochikhin D, Gines P. Renal failure in cirrhosis: prerenal azotemia, hepatorenal syndrome and acute tubular necrosis. Nephrol Dial Transplant 2012a; 27: 2625-8.
4. Schiffl H, Lang SM. Update on biomarkers of acute kidney injury: moving closer to clinical impact? Mol Diagn Ther 2012; 16: 199-207.
5. Kjeldsen L, Cowland JB, Borregaard N. Human neutrophil gelatinase-associated lipocalin and homologous proteins in rat and mouse. Biochim Biophys Acta 2000 Oct 18; 1482: 272-83.
6. Shemin D, Dworkin LD. Neutrophil gelatinase-associated lipocalin (NGAL) as a biomarker for early acute kidney injury. Crit Care Clin 2011; 27: 379-89.
7. Daniels LB, Barrett-Connor E, Clopton P, et al. Plasma neutrophil gelatinase-associated lipocalin is independently associated with cardiovascular disease and mortality in community-dwelling older adults: The Rancho Bernardo Study. J Am Coll Cardiol 2012; 59: 1101-9.
8. Akcay AB, Ozlu MF, Sen N, et al. Prognostic significance of neutrophil gelatinase-associated lipocalin in ST-segment elevation myocardial infarction. J Investig Med 2012; 60: 508-13.
9. Haase M, Bellomo R, Devarajan P, Schlattmann P, Haase-Fielitz A. Accuracy of neutrophil gelatinase-associated lipocalin (NGAL) in diagnosis and prognosis in acute kidney injury: a systematic review and meta-analysis. Am J Kidney Dis 2009; 54: 1012-24.
10. Gerbes AL, Benesic A, Vogeser M, et al. Serum neutrophil gelatinase-associated lipocalin - a sensitive novel marker of renal impairment in liver cirrhosis? Digestion 2011; 84: 82-3.
11. Fagundes C, Pepin MN, Guevara M, et al. Urinary neutrophil gelatinase-associated lipocalin as biomarker in the differential diagnosis of impairment of kidney function in cirrhosis. J Hepatol 2012; 57: 267-73.
12. Verna EC, Brown RS, Farrand E, et al. Urinary neutrophil gelatinase-associated lipocalin predicts mortality and identifies acute kidney injury in cirrhosis. Dig Dis Sci 2012; 57: 2362-70.
13. Olivera-Martinez M, Sayles H, Vivekanandan R, D' Souza S, Florescu MC. Hepatorenal syndrome: are we missing some prognostic factors? Dig Dis Sci 2012; 57: 210-4.
14. Hinz M, Wree A, Jochum C, et al. High age and low sodium urine concentration are associated with poor survival in patients with hepatorenal syndrome. Ann Hepatol 2013; 12: 92-9.
15. Ahn HS, Kim YS, Kim SG, et al. Cystatin C is a good predictor of hepatorenal syndrome and survival in patients with cirrhosis who have normal serum creatinine levels. Hepatogastroenterology 2012; 59: 1168-73.
16. Yang YW, Wu CH, Hu RH, et al. Longitudinal assessment of prognostic factors for patients with hepatorenal syndrome in a tertiary center. Hepatol Int 2010; 4: 507-10.
17. Salerno F, Gerbes A, Ginès P, Wong F, Arroyo V. Diagnosis, prevention and treatment of hepatorenal syndrome in cirrhosis. Gut 2007; 56: 1310-8.
18. Wong F. Management of ascites in cirrhosis. J Gastroenterol Hepatol 2012b; 27: 11-20.
19. Ginès P, Schrier RW. Renal failure in cirrhosis. N Engl J Med 2009; 361: 1279-90.
20. DeLong ER, DeLong DM, Clarke-Pearson DL. Comparing the areas under two or more correlated receiver operating characteristic curves: a nonparametric approach. Biometrics 1988; 44: 837-45.
21. Kamath PS, Kim WR. The model for end-stage liver disease (MELD). Hepatology 2007; 45: 797-805.
22. Kim SY, Yim HJ, Lee J, et al. Comparison of CTP, MELD, and MELD-Na scores for predicting short term mortality in patients with liver cirrhosis. Korean J Gastroenterol 2007; 50: 92-100.
23. Li JY, Deng Q, Wang Y, Xu MY, Lu LG. Prognostic value of the model for end-stage liver disease combined with serum sodium levels in patients with decompensated cirrhosis. Zhonghua Gan Zang Bing Za Zhi 2012; 20: 896-901.
24. Huo TI, Lin HC, Huo SC, et al. Comparison of four model for end-stage liver disease-based prognostic systems for cirrhosis. Liver Transpl 2008; 14: 837-44.
25. Wong F, Nadim MK, Kellum JA, et al. Working Party proposal for a revised classification system of renal dysfunction in patients with cirrhosis. Gut 2011; 60: 702-9.
26. Singer E, Markó L, Paragas N, Barasch J, et al. Neutrophil gelatinase-associated lipocalin: pathophysiology and clinical applications. Acta Physiol (Oxf) 2013; 207: 663-72.
27. Mahdavi-Mazdeh M, Abdollahi A, Nozary Heshmati B, Sobhani Z. Comparison of serum and Urine Neutrophil Gelatinase-associated Lipocalin (NGAL) with serum creatinine in prediction of kidney suitability for transplantation. Nephrourol Mon 2013; 5: 679-82.